Status:
UNKNOWN
A Cognitive Bias Modification RCT for Aggression
Lead Sponsor:
Temple University
Conditions:
Intermittent Explosive Disorder
Eligibility:
All Genders
18-55 years
Phase:
NA
Brief Summary
This randomized controlled trial will test a computerized cognitive bias modification program (CBM) to treat attention and interpretive biases in patients with primary aggression.
Detailed Description
The objective of the proposed study is to test a computerized cognitive bias modification program (CBM) to treat attention and interpretive biases in patients with Intermittent Explosive Disorder, a d...
Eligibility Criteria
Inclusion
- Meet DSM-5 criteria for current IED, as assessed via phone screen and confirmed during an in-person diagnostic interview conducted during visit one of the study
- Are able and willing to cooperate with study protocol; i.e. keep appointments, read and understand consent form, etc.
- Have written and verbal English proficiency for understanding consent and study materials
Exclusion
- Have a lifetime history of psychosis
- Have current moderate to severe substance use disorder
- Have a history of bipolar disorder
- Have current major depressive disorder
- Are younger than 18 or older than 55 years old
- Are currently (past month) receiving treatment for anger or aggression
- Recently (past month) started or changed psychotropic medications
Key Trial Info
Start Date :
May 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2023
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT04819230
Start Date
May 1 2021
End Date
June 1 2023
Last Update
March 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Temple University
Philadelphia, Pennsylvania, United States, 19122